HemaSphere (Jul 2021)
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021
- Jamie Saunders,
- Natalia Curto-Garcia,
- Priya Sriskandarajah,
- Jennifer O’Sullivan,
- Claire Woodley,
- Susan Asirvatham,
- Marion Campbell-Drew,
- Jonathan Mathias,
- Tim Ellis,
- Nona Baker,
- Deepti H. Radia,
- Sahra Ali,
- Shahram Kordasti,
- Patrick Harrington,
- Hugues de Lavallade,
- Donal P. McLornan,
- Claire N. Harrison
Affiliations
- Jamie Saunders
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Natalia Curto-Garcia
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Priya Sriskandarajah
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Jennifer O’Sullivan
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Claire Woodley
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Susan Asirvatham
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Marion Campbell-Drew
- 2 MPN Voice, c/o Guy’s and St Thomas’ Charity, London, United Kingdom
- Jonathan Mathias
- 2 MPN Voice, c/o Guy’s and St Thomas’ Charity, London, United Kingdom
- Tim Ellis
- 2 MPN Voice, c/o Guy’s and St Thomas’ Charity, London, United Kingdom
- Nona Baker
- 2 MPN Voice, c/o Guy’s and St Thomas’ Charity, London, United Kingdom
- Deepti H. Radia
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Sahra Ali
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Shahram Kordasti
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Patrick Harrington
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Hugues de Lavallade
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Donal P. McLornan
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- Claire N. Harrison
- 1 Department of Haematology, Guy’s International Centre of Excellence in Myeloid Disorders, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- DOI
- https://doi.org/10.1097/HS9.0000000000000609
- Journal volume & issue
-
Vol. 5,
no. 7
p. e609
Abstract
No abstracts available.